In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp.
Joly-Guillou
M L
ML
Bergogne-Bérézin
E
E
D000150:Acinetobacter / Q000187:drug effects*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology; D024841:Fluoroquinolones; D015366:Pefloxacin / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C054745:temafloxacin; D015366:Pefloxacin; D002939:Ciprofloxacin; C061363:sparfloxacin